Oral manifestations associated with HIV infection: Evaluation, assessment, and significance

General Dentistry

Volumn 51, Issue 2, 2003, Pages 153-156

  Patel, Anita S H ^a   Glick, Michael ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; TETRADECYL SULFATE SODIUM; VINBLASTINE SULFATE;

ARTICLE; CANDIDIASIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EVALUATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LEUKOPLAKIA; MOUTH DISEASE; MYCOSIS; PATIENT CARE; PHARMACEUTICAL CARE; PROGNOSIS; STATISTICAL SIGNIFICANCE; THRUSH; VIRUS INFECTION; AIDS RELATED COMPLEX; CHEILITIS; MOUTH TUMOR; QUALITY OF LIFE; SURVIVAL RATE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CANDIDIASIS, ORAL; CHEILITIS; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; LEUKOPLAKIA, HAIRY; MOUTH DISEASES; MOUTH NEOPLASMS; QUALITY OF LIFE; SARCOMA, KAPOSI; SURVIVAL RATE;

EID: 2142825103     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fleming PL, Byers PA, Sweeney DD, Karon JM, Janssen RS. HIV prevalence in the United States, 2000. Seattle, WA: 9th Conference on Retroviruses and Opportunistic Infections;2002:Abstract No. 11.
2. Gottlieb MS, Schanker HM, Fan PT, Saxon A, Weisman JD, Pozalski I. Pneumocystis pneumonia - Los Angeles. MMWR 1981; 30:250-252.
3. Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994;77:344-349.
4. Begg MD, Panageas KS, Mitchell-Lewis D, Bucklan RS, Phelan JA, Lamster IB. Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82:276-283.
5. Patton LL. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:182-188.
6. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19.
7. Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001;357:1411-1412.
8. Glick M. The role of the dentist in the era of AIDS. Dent Clin North Am. 1996;40:343-357.
9. Glick M, Berthold P. Oral manifestations of HIV infection. In: Buckley RM, Gluckman SJ, eds. HIV infection in primary care. Philadelphia: W.B. Saunders Co.;2002:132-140.
10. Henning KJ. The virus, its epidemiology, and the natural history of infection. In: Buckley RM, Gluckman SJ, eds. HIV infection in primary care. Philadelphia: W.B. Saunders Co.;2002:3-13.
11. Sifri R, Diaz VA Jr, Gordon L, Glick M, Anapol H, Goldschmidt R, Greenspan D, Sadovsky R, Turner B, Rabinowitz HK. Oral health care issues in HIV disease: Developing a core curriculum for primary care physicians. J Am Board Fam Pract 1988;11:434-444.
12. Kademani D, Glick M. Oral ulcerations in individuals infected with human immunodeficiency virus: Clinical presentations, diagnosis, management, and relevance to disease progression. Quintessence Int 1998;29:523-534.
13. Glick M, Garfunkel AA. Common oral findings in two different diseases - Leukemia and AIDS: Part 1. Compendium 1992;13:432-436.
14. Capoluongo E, Moretto D, Giglio A, Belardi M, Prignano G, Crescimbeni E, Cordiali-Fei P, Maini A, Di Carlo A, Mercantini R, Giannetti A, Ameglio F. Heterogeneity of oral isolates of Candida albicans in HIV-positive patients: Correlation between candidal carriage, karyotype, and disease stage. J Med Microbiol 2000;49:985-991.
15. Campo J, Del Romero J, Castilla J, Garcia S, Rodriguez C, Bascones A. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count, and CD4 lymphocyte percentage in HIV-infected patients. J Oral Pathol Med 2002;31:5-10.
16. Phelan JA, Begg MD, Lamster IB, Gorman J, Mitchell-Lewis D, Bucklan RD, el-Sadr WM. Oral candidiasis in HIV infection: Predictive value and comparison of findings in injecting drug users and homosexual men. J Oral Pathol Med 1997;26:237-243.
17. Greenspan D, Greenspan JS. HIV-related oral disease. Lancet 1996;348:729-733.
18. Felix DH, Watret K, Wray D, Southam JC. Hairy leukoplakia in an HIV-negative, non-immunosuppressed patient. Oral Surg Oral Med Oral Pathol 1992;74:563-566.
19. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr. Changing prevalence of oral manifestations of human immunodeficiency virus in the era of the protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:299-304.
20. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-1869.
21. Leao JC, Porter S, Scully C. Human herpesvirus 8 and oral health care: An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:694-704.
22. Gorsky M, Epstein JB. A case series of acquired immunodeficiency syndrome patients with initial neoplastic diagnoses of intraoral Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:612-617.
23. Epstein JB, Lozada-Nur F, McLeod WA, Spinelli J. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine. Cancer 1989;64:2424-2430.
24. Epstein JB, Scully C. HIV infection: Clinical features and treatment of thirty-three homosexual men with Kaposi's sarcoma. Oral Surg Oral Med Oral Pathol 1991;71:38-41.
25. Muzyka BC, Glick M. Sclerotherapy for the treatment of nodular intraoral Kaposi's sarcoma in patients with AIDS. N Engl J Med 1993;328:210-211.
26. Patton LL, Bonito AJ, Shugars DA. A systematic review of the effectiveness of anti-fungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92: 170-179.